Autism Spectrum Disorder Trial, Recruiting (NCT06600529)

Autism Spectrum Disorder Trial, Recruiting NCT06600529 Sponsor: Iffat Anwar Medical Complex Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06600529 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has been diagnosed with Autism Spectrum Disorder (ASD) according to standard medical guidelines (DSM-5)
The child is between 3 and 12 years old
The child has been on their current medications without changes for at least 4 weeks before joining the study
A parent or legal guardian is willing to give their formal permission for the child to take part

Who may not be able to join:

The child has serious other health conditions alongside their autism diagnosis
The child has previously received stem cell therapy or exosome therapy (a type of cell-based treatment)
The child has had an allergic reaction or sensitivity to any ingredient in the treatments used in this study (confirm with trial site)
The child or family would not be able to follow the steps and requirements of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0092 0300 9400049

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06600529

Sponsor: Iffat Anwar Medical Complex

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 0092 0300 9400049

More information: https://clinicaltrials.gov/study/NCT06600529

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has been diagnosed with Autism Spectrum Disorder (ASD) according to standard medical guidelines (DSM-5)
The child is between 3 and 12 years old
The child has been on their current medications without changes for at least 4 weeks before joining the study
A parent or legal guardian is willing to give their formal permission for the child to take part

Who may not be able to join:

The child has serious other health conditions alongside their autism diagnosis
The child has previously received stem cell therapy or exosome therapy (a type of cell-based treatment)
The child has had an allergic reaction or sensitivity to any ingredient in the treatments used in this study (confirm with trial site)
The child or family would not be able to follow the steps and requirements of the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Iffat Anwar Medical Complex

Registry

ClinicalTrials.gov

Start date

13 August 2024

Est. completion

10 June 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Change in Childhood Autism Rating Scale (CARS) Score (15-60); Change in Childhood Autism Rating Scale (CARS) Score (15-60); Change in Childhood Autism Rating Scale (CARS) Score (15-60); Change in Childhood Autism Rating Scale (CARS) Score (15-60)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov